Name (Synonyms) | Correlation | |
---|---|---|
drug3009 | standard operating procedures Wiki | 1.00 |
drug1497 | Mindfulness Alone (MO) Intervention Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D007239 | Infection NIH | 0.06 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The primary aim of this study is to examine the efficacy of a one-session, hour-long HIPAA-compliant video platform-based mindfulness + compassion telehealth intervention on reducing feelings of loneliness during COVID-19 quarantine. Participants (n=120) currently isolating due to COVID-19 will be randomized to one of three interventions: (a) mindfulness + compassion (MC); (b) mindfulness alone (MO); and (c) waitlist control (WL). The investigators predict that participants in the active intervention groups (mindfulness or mindfulness + compassion) will show a significantly greater reduction in subjective feelings of loneliness at one week follow-up compared to those in the waitlist control group. Additionally, investigators predict that participants in the active intervention groups will show a significantly greater reduction in stress at one week follow-up compared to those in the waitlist control group. Last, investigators predict that participants in the mindfulness + compassion group will show a significantly greater reduction in subjective feelings of loneliness at the 2-week follow-up follow-up relative to those in the mindfulness only group.
Description: Change from baseline in self-reported feelings of loneliness and social isolation. Scores range from 8 to 32, with higher scores indicating higher levels of loneliness.
Measure: Revised University of California Los Angeles Loneliness Scale - 8 (ULS-8) Time: Baseline (Day 0), one-week follow-up (Day 14), two-week follow-up (Day 21)Description: Change from baseline in self-reported feelings of stress. Scores range from 0 to 40, with higher scores indicating more perceived stress.
Measure: Perceived Stress Scale (PSS) Time: Baseline (Day 0), one-week follow-up (Day 14), two-week follow-up (Day 21)Description: Change from baseline in self-reported anxiety symptoms. Scores range from 0 to 21, with higher scores indicating more severe anxiety.
Measure: Generalized Anxiety Disorder - 7 (GAD-7) Time: Baseline (Day 0), one-week follow-up (Day 14), two-week follow-up (Day 21)Description: Change from baseline in self-reported depressive symptoms. Scores range from 0 to 24, with higher scores indicating higher depressive symptom severity.
Measure: Personal Health Questionnaire Depression Scale - 8 (PHQ-8) Time: Baseline (Day 0), one-week follow-up (Day 14), two-week follow-up (Day 21)Description: Change from baseline in self-reported quality of life. Scores range from 0 to 48, with higher scores indicating better quality of life.
Measure: Brunnsviken Brief Quality of Life Scale (BBQ) Time: Baseline (Day 0), one-week follow-up (Day 14), two-week follow-up (Day 21)